Samumed
Samumed
Biotech company developing novel therapeutics for regenerative medicine and oncology.
About
What does Samumed do?
Samumed is a private, clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drugs that activate the Wnt/beta-catenin pathway. Their research targets a wide range of diseases, including degenerative conditions, oncology, and fibrosis.
Where is Samumed headquartered?
Samumed is headquartered in San Diego, United States.
When was Samumed founded?
Samumed was founded in 1997.
What industry does Samumed operate in?
Samumed operates in Biotech, MedTech, Drug Discovery, Clinical Trials, Regenerative Medicine, Oncology.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
Discover innovative AI therapeutics at fibrotherapeutics.ai, enhancing patient care and advancing health technology.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.